Home › Urothelial (Transitional Cell) Carcinoma › Texas › San Antonio
Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa San Antonio, TX
Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Antonio. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
DBC-664 in Adult Patients With Solid Tumors
Nagre-recruitPhase 1
- START San Antonio, San Antonio
A Study of GEN1106 in Participants With Solid Tumors
Nagre-recruitPhase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- START - San Antonio, San Antonio
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Nagre-recruitPhase 3
- USA Operation d/b/a US Clinical Trials, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nagre-recruitPhase 1
- START San Antonio, San Antonio
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Clinical Trial Site, San Antonio
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Nagre-recruitPhase 1/2
- Next Oncology-Oncology, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Nagre-recruitPhase 1
- Dren Investigational Site, San Antonio
Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod
- Nashville, TN23 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX19 pag-aaral
- Dallas, TX18 pag-aaral
- Edison, NJ18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Queens, NY15 pag-aaral
- Chicago, IL14 pag-aaral
- Arlington, VA12 pag-aaral
- Boston, MA11 pag-aaral
- Austin, TX10 pag-aaral
- Orange, CA10 pag-aaral
Iba pang pag-aaral sa San Antonio
- Non-Small Cell Lung Cancer59 pag-aaral
- Kanser sa Suso47 pag-aaral
- Colorectal Cancer46 pag-aaral
- Metastatic Cancer44 pag-aaral
- Kanser (lahat ng uri)41 pag-aaral
- Obesity40 pag-aaral
- Type 2 Diabetes37 pag-aaral
- Overweight34 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Pancreas31 pag-aaral
- Kanser sa Prostate28 pag-aaral
- Kanser ng Endometrium27 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.